Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
Millar JS, Maugeais C, Ikewaki K, Kolansky DM, Barrett PH, Budreck EC, Boston RC, Tada N, Mochizuki S, Defesche JC, Wilson JM, Rader DJ. Millar JS, et al. Among authors: barrett ph. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):560-5. doi: 10.1161/01.ATV.0000155323.18856.a2. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637307
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Millar JS, et al. Among authors: barrett ph. Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1350-6. doi: 10.1161/01.ATV.0000219695.84644.56. Epub 2006 Mar 30. Arterioscler Thromb Vasc Biol. 2006. PMID: 16574893 Clinical Trial.
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Cohn JS, Wilson A, Wolfe ML, Nartsupha C, Schaefer PM, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ. Millar JS, et al. Among authors: barrett ph. J Lipid Res. 2008 Mar;49(3):543-9. doi: 10.1194/jlr.M700268-JLR200. Epub 2007 Nov 21. J Lipid Res. 2008. PMID: 18033754 Free article. Clinical Trial.
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content.
Telford DE, Lipson SM, Barrett PH, Sutherland BG, Edwards JY, Aebi JD, Dehmlow H, Morand OH, Huff MW. Telford DE, et al. Among authors: barrett ph. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2608-14. doi: 10.1161/01.ATV.0000189158.28455.94. Epub 2005 Oct 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 16210564
256 results